Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... may suppress bone marrow function, manifested by thrombocytopenia, neutropenia, and anemia. Monitor blood counts and omit or modify dose for hematologic toxicities. ... 6:00-8:00 p.m. (Central) Poster Title: "Stem Cell Transplant (SCT) and Pralatrexate Therapy: Outcome of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Who Received ...
2009 NOV 23 ... and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. ... Capital Markets, Finance, Financial, Investing, Investment, Technology, Pharmaceuticals, Therapy, Treatment, AMAG Pharmaceuticals Inc. This article was prepared by Biotech ...
2009 NOV 23 ... potentially serious medical condition, such as lupus, thyroid disease or iron-deficiency anemia. Other causes of hair loss include drug reactions, birth control pills, menopause or a ... suggested that hair transplant patients supplement their treatment with a medical therapy recommended by their dermatologist. Adult Acne Occurs More Frequently in ...
2009 NOV 23 ... Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, ... Breast Carcinoma, Chemotherapy, Clinical Trial Research, Deep Vein Thrombosis, Drug Therapy, Epidemiology, Erythropoiesis, Erythropoietin, FDA, Hematology, Medical Device, ...
2009 NOV 23 ... patients with HFE mutations." "on HD for > 90 days with no cause of anemia except chronic kidney disease were tested for HFE mutations (H63D and C282Y). ... Hemodialysis, Iron Overload, Kidney Disease, Metabolism, Renal Dialysis, Therapy, Treatment, Wellness, University of Glasgow. This article was prepared by ...
2009 NOV 23 ... survival was 254 days. Major adverse events of Grade 3 or 4 were neutropenia (27.5%), anemia (12.5%), diarrhea (2.5%) and sensory neuropathy (2.5%)," wrote W. Koizumi and ... M gimestat-1 M otastat potassium) monotherapy in 32 patients and S-1-based combination therapy in 5. The median number of administered courses of paclitaxel was 3.5 (1-14). The ...
2009 NOV 23 ... or platelet count and metastasis/platelet count were shown. Monocytosis, anemia, and thrombocytosis were demonstrated to have a cumulative effect on the prognosis of ... Head and Neck Neoplasms, Hematology, Monocytosis, Oncology, Post-Trials Research, Therapy, Thrombocytosis, Treatment, National University. This article was prepared ...
2009 NOV 23 ... "Androgen-deprivation therapy (ADT) causes loss of libido, vasomotor flushing, anemia, and fatigue. More recently, ADT has been shown to accelerate bone loss, increase fat ...
2009 NOV 16 ... to prednisolone, mental change, left side weakness, fever, thrombocytopenia, hemolytic anemia, and renal failure developed. Despite intravenous immunoglobulin therapy and ...
2009 NOV 23 ... finding at endoscopy, and ulceration with occult blood loss leading to iron deficiency anemia (IDA) is even rarer." "The choice of therapeutic procedure to treat ... Country:United States, Anemia, Endoscopy, Hematology, Iron Deficiency, Lipoma, Surgery, Therapy, Treatment, Ulcer, Wright State University, Medical Department. This ...
2009 NOV 16 ... The most common toxicities were bone marrow suppression-related neutropenia and anemia, which were minor. The clinical response rate was disappointing for the combination of ... mononuclear cells (PBMC) were analyzed to evaluate epigenetic changes in response to therapy. EBV titers were evaluated as a surrogate measure for gene re-expression of epigenetic ...
2009 NOV 16 ... a credible online resource addressing bleeding and clotting disorders, anemia, and cancer. The official journal of ASH is Blood (www.bloodjournal.org), the most cited ... is Professor of Medicine and Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation, University of Toronto, and Director, Cell Therapy Program, Princess ...
2009 NOV 16 ... a credible online resource addressing bleeding and clotting disorders, anemia, and cancer. The official journal of ASH is Blood (www.bloodjournal.org), the most cited ... of his students and fellows remaining engaged in academic hematology-oncology or gene therapy research at leading research institutions worldwide. Some of his trainees have gone on ...
2009 NOV 16 ... in female patients and in female partners of male patients. Ribavirin causes hemolytic anemia. The anemia associated with REBETOL therapy may result in a worsening of cardiac ...
2009 NOV 23 ... timing of radiation therapy relative to surgery and presence of a moderate or severe anemia were significantly related to survival. The median survival was 310 days for cats ...
2009 NOV 16 ... of hepatitis C by delivering similar efficacy to ribavirin but with significantly less anemia, which is the main treatment-limiting toxicity associated with ribavirin. ... Meeting in Boston. It is believed that taribavirin (TBV) may present an alternative therapy to ribavirin (RBV) for the treatment of hepatitis C by delivering similar efficacy to ...
2009 NOV 23 ... effects in both arms of the study include neutropenia and fatigue, hypokalemia, nausea, anemia, leucopenia, and alopecia. Palifosfamide is easily administered as an out-patient ... Sunitinib Maleate, Sutent, Synovial Sarcoma, Testicular Cancer, Testicular Diseases, Therapy, Treatment, U.S. Food and Drug Administration, Urology, ZIOPHARM Oncology Inc. ...
